CS Medica is a Danish company active in medical technology. The company specializes in the development of new medical treatments. The portfolio includes medical cannabis (CBD) products, with the greatest focus on dietary supplements and various treatment care. The products are used, for example, by patients suffering from psoriasis, osteoarthritis, and hair loss. The largest operations are found in the Nordic market, where the products are resold under their own brand.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Gitte Henriksen | 36,69 | 36,69 | 2022-06-03 |
| Lone Henriksen | 36,54 | 36,54 | 2022-06-22 |
| Finn-Ove Henriksen and Nina Henriksen | 3,31 | 3,31 | 2022-03-31 |
| Ylber Rexhepi | 2,30 | 2,30 | 2022-03-31 |
| Tonoy Sayeed | 1,45 | 1,45 | 2022-03-31 |
| Michael Kaa Andersen | 1,18 | 1,18 | 2022-03-31 |
| Kent Eklund | 1,02 | 1,02 | 2022-03-31 |
| Taulant Bara | 1,02 | 1,02 | 2022-03-31 |
| Diaz Capital Invest AB | 0,91 | 0,91 | 2022-02-03 |
| Thomas Gidlund | 0,89 | 0,89 | 2022-03-31 |
2022-08-19 Delårsrapport 2022-Q3
2022-11-18 Bokslutskommuniké 2022